FATE

Fate Therapeutic

1.51

0.05+3.42%

After Hours: 1.505 -0.01 -0.36%19:55 02/23 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.450/1.460

TODAY RANGE1.405-1.540

VOL1.88M

MARKET CAP174.18M

52 WEEK RANGE0.6611-1.940

AVG VOL (3M)1.53M

% TURNOVER1.63%

TURNOVER--

P/E (TTM)-1.1450

% RANGE9.25%

EPS(TTM)-1.3188

P/E(FORWARD)-1.3246

P/B0.7441

BVPS2.029

DIVIDEND--

P/S12.63

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP170.87M

SHARES OUTSTANDING115.35M

NEXT EARNINGS03/03-03/09

FREE FLOAT113.16M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·02/03 21:05
Fate Therapeutics gewährt neuem Mitarbeiter Aktienoptionen und RSUs als Einstiegsvergütung
Reuters·02/03 21:05
Fate Therapeutics Grants Stock Options and RSUs to New Employee Under Inducement Plan
Reuters·02/03 21:05
FATE THERAPEUTICS REPORTS NEW EMPLOYEE INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(C)(4)
TipRanks·01/13 02:01
Top Fate Therapeutics Insider Makes a Quiet Move That Investors Can’t Ignore
Reuters·01/05 21:05
Fate Therapeutics Grants Stock Options and RSUs to New Employees
Reuters·01/05 21:05
FATE THERAPEUTICS REPORTS NEW EMPLOYEE INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(C)(4)
TipRanks·01/05 11:50
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Fate Therapeutics (FATE) and Alto Neuroscience, Inc. (ANRO)
TipRanks·12/09/2025 13:36
Fate Therapeutics (FATE) Gets a Buy from Wedbush
TipRanks·12/08/2025 13:21
Fate Therapeutics presents updated Phase 1 data of FT819
Reuters·12/08/2025 13:00
Fate Therapeutics Reports Promising Phase 1 Results for Off-the-Shelf CAR T-Cell Therapy in Lupus
Reuters·11/25/2025 13:00
Fate Therapeutics to Present at Piper Sandler Annual Healthcare Conference
TipRanks·11/18/2025 03:55
Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts
TipRanks·11/17/2025 07:30
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP)
TipRanks·11/16/2025 06:00
Navigating Data Privacy Challenges: Fate Therapeutics’ Battle with Regulatory Compliance and Business Risks
TipRanks·11/15/2025 17:35
Fate Therapeutics (FATE) Receives a Hold from Bank of America Securities

Same Industry

Name/Symbol

Change%

Price

Fate Therapeutic

FATE

+3.42%

1.51

Regeneron Pharmaceuticals

REGN

+0.95%

787.04

GridAI Tech

GRDX

-8.91%

2.35

BIONTECH

BNTX

-0.20%

109.93

United Therapeutics Corp.

UTHR

+0.23%

474.52

Vertex Pharmaceuticals Inc

VRTX

+0.86%

481.01

Siga Technologie

SIGA

-0.59%

6.71

Moderna

MRNA

+0.84%

50.29

Charles Riv Labs Intl Inc

CRL

-3.20%

163.52

Medpace Holdings

MEDP

-1.94%

444.96

Talphera Inc

TLPH

+20.92%

0.9391

ICON PLC

ICLR

+4.97%

104.66

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

-2.00%

162.31

MOLECULAR PARTNERS AG

MOLN

0.00%

5.00

Arcturus Therape

ARCT

0.00%

7.67

Gilead Sciences Inc

GILD

-1.04%

149.83

PRA Health

PRAH

165.21

Incyte Corp

INCY

-0.47%

100.85

Aptevo Therapeutics Inc

APVO

-5.41%

6.30

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.